Fertility News and Research

RSS

NBER project identifies and analyzes African successes

Conventional wisdom has long been negative on Africa. Historically, it has been seen as a failing continent, plagued by deep-rooted problems - poverty, corruption, war, and disease. But after four decades of relative stagnation, Africa has been growing rapidly. Since the 1990s, many African countries have seen economic and political improvements, more transparent elections, increased democracy and freedom of press. But these successes are not well understood.

21 Oct 2010

Vitro signs contract with HemoGenix to manufacture, distribute stem cell analysis tools

Vitro Diagnostics, Inc., dba Vitro Biopharma, announced that it signed an amendment to its contract to jointly manufacture and distribute stem cell analysis tools with HemoGenix, Inc., a leading firm known for its pioneering HALO analysis platform for stem cells.

20 Oct 2010

Reproductive Specialists of New York opens new office in Brooklyn

Reproductive Specialists of New York announces the opening of its new Brooklyn office, the newest addition to their five locations.

19 Oct 2010

New data on Merck’s odanacatib for osteoporosis in postmenopausal women presented at 32nd ASBMR

New data on odanacatib, an investigational cathepsin-K (Cat-K) inhibitor in development for the treatment of osteoporosis in postmenopausal women, were presented at the 32nd Annual Meeting of the American Society for Bone and Mineral Research (ASBMR) in Toronto, Canada.

19 Oct 2010

Genetic variations linked to early menopause: Study

In a new study scientists have found that particular genetic variations are linked to early menopause before the age of 45. They compared the DNA of more than 2,000 women who had experienced early menopause with that of women who had menopause later than 45 years.

19 Oct 2010

Researchers identify genes that predict early menopause

The first research from the Breakthrough Generations Study could lead to a test to predict a woman's reproductive lifespan. The findings, published today in Human Molecular Genetics, could have considerable impact on women in the UK and other western countries, where many start having children at a later age. Early menopause affects one in 20 UK women.

18 Oct 2010

Victorian abortion clinics ask for exclusion zones

There is a proposal for exclusion zones around Victorian abortion clinics to stop protesters harassing patients and staff.

17 Oct 2010

Taller kids with IVF: Study

A new study has found that children born via IVF are typically taller than those born naturally. Newborn IVF babies created from a fresh embryo transferred back into the mother, also tended to be about 190g lighter than naturally conceived children.

13 Oct 2010

NHC enter agreement with Attain to offer new program for IVF fertility treatments

IntegraMed America, Inc. the leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets, today announced that its Attain Fertility Centers division has entered into an agreement with The New Hope Center for Reproductive Medicine (NHC) to begin offering the Attain IVF family of specialty financing Programs.

13 Oct 2010

Incept completes first U.S. human clinical trial of SMART Start Embryo Culture System

Incept BioSystems, Inc. a privately-held biomedical device company using patented, microfluidic technology developed at the University of Michigan, announced today the completion of the first U.S. human clinical trial of its proprietary, SMART Start Embryo Culture System, and the recent submission of a 510(k) application to the U.S. Food & Drug Administration.

13 Oct 2010

Woman’s socioeconomic status impacts clinicians' decisions for contraception: Study

A woman's race/ethnicity and socioeconomic status impact whether health care providers recommend one of the most highly effective forms of contraception, a UCSF study confirms. The results also indicate that the interaction of both factors plays a role in clinicians' decisions.

12 Oct 2010

Erbitux-based therapy helps in early tumor shrinkage, long-term survival in mCRC patients with KRAS wild-type tumors

Merck Serono, a division of Merck KGaA, Darmstadt, Germany has announced that new data presented today at the 35th Congress of the European Society for Medical Oncology (ESMO) have shown that patients with KRAS wild-type metastatic colorectal cancer (mCRC) who experienced early tumor shrinkage (within 8 weeks) during 1st line Erbitux (cetuximab) based treatment lived a median of 28.3 months.

12 Oct 2010

Fertility concerns of cancer survivors inadequately addressed, study finds

Many cancer survivors experience changes in sexual function that leave them feeling guilty and a longing for intimacy, Australian researchers told at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy. The researchers say that these sexuality and fertility concerns are often not adequately addressed by doctors.

11 Oct 2010

Baby born from 20 year old frozen embryo

A 42 year old mother gave birth to a baby born from an embryo frozen 20 years ago. This is the longest time a fertilized egg has been stored before developing into a healthy baby, and could eventually lead to thousands of women having children in middle age feel experts.

11 Oct 2010

Merck Serono announces first results from Erbitux BALI-1 study in metastatic triple-negative breast cancer

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced the first results from the BALI-1 study of Erbitux® (cetuximab) in the treatment of metastatic triple-negative breast cancer (TNBC), an aggressive cancer in which early relapse and metastasis are common. The data, presented during the 35th Congress of the European Society for Medical Oncology (ESMO), demonstrate that Erbitux has the potential to improve outcomes for women with this relentlessly devastating cancer.

11 Oct 2010

American Cancer Society awards 94 national research, training grants to 70 institutions nationwide

The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has awarded 94 national research and training grants totaling $46,633,000 to 70 institutions nationwide in the first of two grants cycles for 2011.

7 Oct 2010

European infertility patients are limited in choice for medically assisted reproduction treatment

In a number of European countries, infertility patients are limited in their choice for medically assisted reproduction treatment, experts criticized today at the European Health Forum Gastein. Many patients seek treatment outside their home countries.

6 Oct 2010

ESHRE workshop highlights problems related to MAR treatment in Europe

European patients are in many countries, in fact, limited in their individual choice of medically assisted reproduction (MAR) treatment, experts from the European Society of Human Reproduction and Embryology (ESHRE) stressed today at the European Health Forum Gastein (EHFG).

6 Oct 2010

IVF pioneer wins Nobel prize three decades after groundbreaking work

Yesterday's announcement that a pioneer of in vitro fertilization (IVF) for humans has won the Nobel prize for medicine three decades after his groundbreaking work adds new historical perspective to advancements in reproductive medicine, a sharp reminder of how a once-feared technology has transformed into a highly popular and routine treatment for infertility, said one of Southern California's earliest fertility doctors.

6 Oct 2010

Study on potential advantages and disadvantages of medical tourism

Medical tourism is to go under the microscope in a major new study, led by an academic from the University of York, which aims to assess its potential advantages and disadvantages.

6 Oct 2010

Fertility News and Research

NBER project identifies and analyzes African successes

Vitro signs contract with HemoGenix to manufacture, distribute stem cell analysis tools

Reproductive Specialists of New York opens new office in Brooklyn

New data on Merck’s odanacatib for osteoporosis in postmenopausal women presented at 32nd ASBMR

Genetic variations linked to early menopause: Study

Researchers identify genes that predict early menopause

Victorian abortion clinics ask for exclusion zones

Taller kids with IVF: Study

NHC enter agreement with Attain to offer new program for IVF fertility treatments

Incept completes first U.S. human clinical trial of SMART Start Embryo Culture System

Woman’s socioeconomic status impacts clinicians' decisions for contraception: Study

Erbitux-based therapy helps in early tumor shrinkage, long-term survival in mCRC patients with KRAS wild-type tumors

Fertility concerns of cancer survivors inadequately addressed, study finds

Baby born from 20 year old frozen embryo

Merck Serono announces first results from Erbitux BALI-1 study in metastatic triple-negative breast cancer

American Cancer Society awards 94 national research, training grants to 70 institutions nationwide

European infertility patients are limited in choice for medically assisted reproduction treatment

ESHRE workshop highlights problems related to MAR treatment in Europe

IVF pioneer wins Nobel prize three decades after groundbreaking work

Study on potential advantages and disadvantages of medical tourism

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News